Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU

Deep Vein Thrombosis Clinical Trial

— COVIDOP-DVT  

Official title:

Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04363528
• Other study ID #: P20/08_COVIDOP-DVT
• Status: Completed
• Phase: N/A
• Start date: April 24, 2020
• Est. completion date: June 24, 2021

Study information

• Verified date: July 2022
• Source: Versailles Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The main objective of the study is to determine the incidence of deep vein thromboses at Doppler echo in patients with SARS-Cov-2 pneumopathy upon their entry into ICU and after 7 days of hospitalization in ICU.

This is a monocentric interventional study (RIPH 2).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: June 24, 2021
• Est. primary completion date: December 24, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient > or =18 years

• Hospitalization in intensive care

• PCR COVID 19+ or compatible clinical signs (fever, cough, myalgia, asthenia, loss of taste, anosmia) associated with compatible radiological signs

Exclusion Criteria:

• Pregnancy in progress

• Patient <18 years

• Patients deprived of freedoms or under guardianship

• Patient or family opponent of protocol participation

• patient on curative anticoagulant for more than 48H00

• impossible Venous Doppler Echo

Related Conditions & MeSH terms

• Deep Vein Thrombosis
• Thrombosis
• Venous Thrombosis

Intervention

Other:
• Doppler Echo
2 doppler echo will be done at patients hospitalized in ICU and with SARS-CoV-2 pneumopathy at 7 days apart

Locations

Country	Name	City	State
France	Centre Hospitalier de Versailles	Le Chesnay

Sponsors (1)

Lead Sponsor	Collaborator
Versailles Hospital

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU	Deep vein thrombosis at Doppler echo	Day 0
Primary	Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU	Deep vein thrombosis at Doppler echo	Day 7